{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:19Z","timestamp":1791304399863,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2020R1A2C1010378"],"award-info":[{"award-number":["2020R1A2C1010378"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejon.2025.103031","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:13:45Z","timestamp":1761930825000},"page":"103031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-1374","authenticated-orcid":false,"given":"Myoung Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2025.103031_bib1","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41598-024-53711-y","article-title":"Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma","volume":"14","author":"Bai","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejon.2025.103031_bib2","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.3748\/wjg.v26.i30.4442","article-title":"Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer","volume":"26","author":"Bian","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejon.2025.103031_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41747-021-00204-6","article-title":"Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting Survival\u2014prospective interventional study","volume":"5","author":"Bessar","year":"2021","journal-title":"Eur. Radiol. Exp."},{"key":"10.1016\/j.ejon.2025.103031_bib4","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/CMAR.S308097","article-title":"A comparison of adverse events among radiofrequency ablation, conventional transarterial chemoembolization (TACE) and drug-eluting bead TACE in treating hepatocellular carcinoma patients","volume":"13","author":"Cao","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejon.2025.103031_bib5","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.3390\/ijms21218165","article-title":"Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejon.2025.103031_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000512028","article-title":"Clinical-Radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma","volume":"10","author":"Chen","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejon.2025.103031_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.17998\/jlc.2023.05.22","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver cancer association","volume":"23","author":"Cho","year":"2023","journal-title":"J. Liver Cancer"},{"key":"10.1016\/j.ejon.2025.103031_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/cco-20-107","article-title":"Imaging diagnosis of hepatocellular carcinoma: LI-RADS","volume":"10","author":"Cunha","year":"2021","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.ejon.2025.103031_bib9","article-title":"Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium","volume":"44","author":"Franzoi","year":"2024","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"10.1016\/j.ejon.2025.103031_bib10","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.21037\/jgo-21-370","article-title":"Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis","volume":"12","author":"Guo","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ejon.2025.103031_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ANS.0000000000000423","article-title":"Advances in conceptual and methodological issues in symptom cluster research: a 20-year perspective","volume":"45","author":"Harris","year":"2022","journal-title":"Adv. Nurs. Sci."},{"key":"10.1016\/j.ejon.2025.103031_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4103\/jcrt.jcrt_132_21","article-title":"Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization","volume":"17","author":"He","year":"2021","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.ejon.2025.103031_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08830185.2024.2411998","article-title":"Transforming growth factor-\u03b2 in tumor microenvironment: understanding its impact on monocytes and macrophages for its targeting","volume":"44","author":"Hourani","year":"2025","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ejon.2025.103031_bib14","first-page":"61","article-title":"Post-embolisation syndrome (PES): risk factors & prognosis in hepatocellular carcinoma (HCC) patients undergoing trans-arterial chemoembolisation (TACE)","volume":"29","author":"Jaafar","year":"2024","journal-title":"Chronicles Surg."},{"key":"10.1016\/j.ejon.2025.103031_bib15","first-page":"817","article-title":"Managing postembolization syndrome through a machine learning\u2013based clinical decision support system: a randomized controlled trial","volume":"42","author":"Kang","year":"2024","journal-title":"Comput. Inf. Nurs."},{"key":"10.1016\/j.ejon.2025.103031_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jvir.2023.10.019","article-title":"Immune effects of intra-arterial liver-directed therapies","volume":"35","author":"Karimi","year":"2024","journal-title":"J. Vasc. Intervent. Radiol."},{"key":"10.1016\/j.ejon.2025.103031_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2018180257","article-title":"A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma","volume":"290","author":"Khalaf","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ejon.2025.103031_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110637","article-title":"Ischemic preconditioning attenuates endoplasmic reticulum stress-dependent apoptosis of hepatocytes by regulating autophagy in hepatic ischemia-reperfusion injury","volume":"122","author":"Kong","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejon.2025.103031_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/jcm14020314","article-title":"All you need to know about TACE: a comprehensive review of indications, techniques, efficacy, limits, and technical advancement","volume":"14","author":"Lanza","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejon.2025.103031_bib20","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.3390\/cancers13205122","article-title":"European multicenter study on degradable starch microsphere TACE: the digestible way to conquer HCC in patients with high tumor burden","volume":"13","author":"Ludwig","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejon.2025.103031_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12876-021-01839-w","article-title":"Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejon.2025.103031_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309693","article-title":"Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: a 5-year real world experience","volume":"19","author":"Makary","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ejon.2025.103031_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1186\/s12885-019-5989-2","article-title":"Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study","volume":"19","author":"Miksad","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejon.2025.103031_bib24","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cancers16091618","volume":"16","author":"Minici","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ejon.2025.103031_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.822507","article-title":"Transarterial chemoembolization for hepatocellular carcinoma in clinical practice: temporal trends and survival outcomes of an iterative treatment","volume":"12","author":"Pelizzaro","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejon.2025.103031_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejon.2025.103031_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.avsg.2024.12.079","article-title":"Dexamethasone-based prophylactic therapy for prevention of post-embolization syndrome: a systematic review and meta-analysis assessing its efficacy and influence of dosage and Timing in patients undergoing arterial embolization","volume":"113","author":"Raza","year":"2025","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.ejon.2025.103031_bib28","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/sim.9025","article-title":"Minimum sample size for external validation of a clinical prediction model with a binary outcome","volume":"40","author":"Riley","year":"2021","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejon.2025.103031_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000252","article-title":"Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis","volume":"7","author":"Roehlen","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejon.2025.103031_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14646","article-title":"Interventional oncological treatment of hepatocellular carcinoma (HCC) - a single-center long-term evaluation of thermoablation techniques like LITT, MWA, and TACE in a multimodal application over 26 years","volume":"9","author":"Vogl","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejon.2025.103031_bib31","article-title":"The therapeutic principle of combined clearing heat and resolving toxin plus TACE on primary liver cancer: a systematic review and meta-analysis","volume":"319","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejon.2025.103031_bib32","first-page":"1","article-title":"Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma","volume":"16","author":"You","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ejon.2025.103031_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0898010120958859","article-title":"Quality of life among breast and colon cancer patients before and after first-cycle chemotherapy","volume":"39","author":"Zamel","year":"2021","journal-title":"J. Holist. Nurs."},{"key":"10.1016\/j.ejon.2025.103031_bib34","doi-asserted-by":"crossref","first-page":"b167","DOI":"10.1007\/s12094-018-1902-8","article-title":"CalliSpheres\u00ae drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study","volume":"21","author":"Zhang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejon.2025.103031_bib35","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.62347\/PJVG6340","article-title":"Clinical predictors for liver function impairment and post-embolization syndrome following transcatheter arterial chemoembolization in primary hepatic carcinoma patients: a retrospective study","volume":"15","author":"Zhao","year":"2025","journal-title":"Am. J. Cancer Res."}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388925002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388925002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:11:20Z","timestamp":1773817880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388925002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S1462388925002558"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2025.103031","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2025.103031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103031"}}